GAMMA Investing’s Gossamer Bio GOSS Stock Holding History

GAMMA Investing’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$521	Buy	44 +28	+175%	+$363	﹤0.01%	4204
2026 Q2	$206	Buy	+16	New	+$357	﹤0.01%	4091
2026 Q1	–	Sell	-6	Closed	-$1.45K	–	4170
2025 Q4	$1.45K	Buy	+6	New	+$1.37K	﹤0.01%	3695

Other funds holding GOSS

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

GAMMA Investing's GOSS Position: Q3 2026 in Review

GAMMA Investing increased its Gossamer Bio (GOSS) stake by 175% in Q3 2026, buying an estimated $363 and bringing the position to 44 shares worth $521. The position accounts for ﹤0.01% of the portfolio, ranked #4204.

GAMMA Investing first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.45K in Q4 2025. 3 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

GAMMA Investing held 44 shares of Gossamer Bio worth $521 as of Q3 2026.
GAMMA Investing bought 28 Gossamer Bio shares in Q3 2026, an estimated $363.
Gossamer Bio made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4204 holding.
GAMMA Investing first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
GAMMA Investing's Gossamer Bio position peaked at $1.45K in Q4 2025.
3 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.